REILLY FINANCIAL ADVISORS, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 289 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
REILLY FINANCIAL ADVISORS, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$35,000
+400.0%
160
+166.7%
0.00%
+200.0%
Q4 2020$7,000
+16.7%
600.0%0.00%0.0%
Q3 2020$6,000
-14.3%
600.0%0.00%0.0%
Q2 2020$7,000
+40.0%
600.0%0.00%0.0%
Q1 2020$5,000
+150.0%
60
+200.0%
0.00%
Q4 2019$2,0000.0%200.0%0.00%
Q3 2019$2,000
-33.3%
200.0%0.00%
Q2 2019$3,0000.0%200.0%0.00%
Q1 2019$3,000
-50.0%
20
-66.7%
0.00%
-100.0%
Q4 2018$6,000
-40.0%
600.0%0.00%0.0%
Q3 2018$10,000
+25.0%
600.0%0.00%0.0%
Q2 2018$8,000
+14.3%
600.0%0.00%0.0%
Q1 2018$7,000
+133.3%
60
+200.0%
0.00%
Q4 2017$3,000
+50.0%
200.0%0.00%
Q3 2017$2,0000.0%200.0%0.00%
Q2 2017$2,0000.0%200.0%0.00%
Q1 2017$2,0000.0%200.0%0.00%
Q4 2016$2,000
-33.3%
200.0%0.00%
-100.0%
Q3 2016$3,000
-40.0%
20
-60.0%
0.00%0.0%
Q2 2014$5,000500.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2020
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 3,455,054$456,102,0008.18%
Consonance Capital Management LP 675,492$89,172,0008.05%
Prisma Capital Partners LP 33,000$4,356,0004.11%
Broadfin Capital, LLC 122,930$16,228,0002.65%
Rock Springs Capital Management LP 354,000$46,732,0002.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 339,180$44,775,0001.76%
GREAT POINT PARTNERS LLC 75,000$9,901,0001.69%
Atika Capital Management LLC 31,000$4,092,0001.58%
Sivik Global Healthcare LLC 30,000$3,960,0001.47%
Sio Capital Management, LLC 19,000$2,508,0001.41%
View complete list of GW PHARMACEUTICALS PLC shareholders